Aeris Environmental Ltd (ASX: AEI) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Aeris Environmental Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $16.22 million
P/E Ratio 17.30
Dividend Yield 0.00%
Shares Outstanding 245.69 million
Earnings per share -0.015
Dividend per share N/A
Year To Date Return 65.00%
Earnings Yield 5.78%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Aeris Environmental Ltd (ASX: AEI)
    Latest News

    Share Market News

    Aeris (ASX:AEI) share price charges 6% higher on partnership deal

    The Aeris Environmental Ltd (ASX: AEI) share price rose by nearly 7% today as the company announced that it has…

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    ⏸️ Investing

    10 stocks up by more than 50% in the past month

    The market has gone nowhere in the past month, but these 10 stocks are up by more than 50%

    Read more »

    AEI ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Aeris Environmental Ltd

    Aeris Environmental Ltd is engaged in the research, development, commercialization of proprietary technologies, and distribution of the AerisGuard products and provides HVAC/R Hygiene and Remediation Technology, and Energy Efficiency services. The company provides various solutions and products such as Aerisview, Aerisguard Polymers, Aeris Smarthub, Bioactive Coil Treatment, Multi Enzyme Coil Cleaner, Surface Treatment, HD Cleaner, and others. Its geographic reportable segments are Australia and International. The company generates a majority of its revenue from Australia.

    AEI Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    22 May 2024 $0.07 $0.00 0.00% 63,399 $0.07 $0.07 $0.06
    20 May 2024 $0.07 $0.00 0.00% 24,387 $0.07 $0.07 $0.06
    15 May 2024 $0.06 $0.00 0.00% 94,564 $0.06 $0.06 $0.06
    14 May 2024 $0.06 $0.00 0.00% 157,515 $0.07 $0.07 $0.06
    13 May 2024 $0.07 $0.00 0.00% 154,109 $0.07 $0.07 $0.06
    10 May 2024 $0.07 $0.00 0.00% 150,362 $0.07 $0.07 $0.07
    08 May 2024 $0.07 $0.00 0.00% 1 $0.07 $0.07 $0.07
    07 May 2024 $0.07 $0.00 0.00% 48,457 $0.07 $0.07 $0.07
    06 May 2024 $0.07 $0.01 15.38% 7,159 $0.07 $0.07 $0.07
    03 May 2024 $0.07 $-0.01 -14.08% 1 $0.07 $0.07 $0.07
    01 May 2024 $0.07 $0.00 0.00% 261,630 $0.07 $0.07 $0.06
    30 Apr 2024 $0.07 $0.00 0.00% 252,983 $0.07 $0.07 $0.07
    29 Apr 2024 $0.07 $0.00 0.00% 230,621 $0.07 $0.07 $0.07
    26 Apr 2024 $0.07 $0.00 0.00% 120,301 $0.06 $0.07 $0.06
    24 Apr 2024 $0.07 $0.01 16.39% 88,819 $0.07 $0.07 $0.07
    23 Apr 2024 $0.06 $0.00 0.00% 20,513 $0.06 $0.06 $0.06

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Maurie Stang Non-Executive ChairmanNon-Executive Director Jul 2002
    Mr Stang has more than three decades of experience building and managing companies in the healthcare and biotechnology industry in Australia and internationally. His business development and marketing skills have resulted in the commercialization of intellectual property across global markets. He is member of the Risk and Corporate Governance Committee.
    Mr Steven Kritzler Non-Executive Director Feb 2005
    Mr Kritzler is the Technical Director of Novapharm Research (Australia) Pty Ltd. Mr Kritzler has over 40 years of experience in commercial R&D in the areas of pharmaceutical, medical, cosmetic and specialty industrial products.
    Dr Jenny Lee Harry Non-Executive Director Apr 2021
    Dr Harry has 25 years of experience in executive management of companies in the biotechnology, diagnostic and pharmaceutical sectors. She is a CEO with experience in growing companies from start-up to commercialisation, and has demonstrated expertise in building teams, establishing global partnerships, capital raising, investor relations, together with corporate governance and compliance. He is Chair of Risk and Corporate Governance Committee and member of the Related Parties Committee.
    Dr Abbie Widin Non-Executive Director Mar 2021
    Dr Widin has over 20 years of experience in global consumer goods, consulting and proptech. Dr Widin has held various marketing, commercial and international management roles in both private and public companies, such as Procter & Gamble (Australia and Europe) and Kellogg (Asia Pac). She is an owner of companies supplying facade management and soft services to the commercial real estate market. Dr Widin has strengths in go-to-market strategy, innovation pipelines and leading cross-functional teams. He is also Chair of Related Parties Committee.
    Mr Andrew Ian Just Chief Executive Officer Mar 2022
    -
    Mr Robert John Waring Company Secretary Jul 2002
    -
    Andrew Ian Just Chief Executive Officer
    -
    Robert John Waring Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Hsbc Custody Nominees (Australia) Limited 35,352,171 14.39%
    Bernard Stang 18,043,084 7.35%
    Maurie Stang 15,279,749 6.22%
    Steven Kritzler <S Kritzler Family A/C> 8,331,609 3.39%
    Girdis Superannuation Pty Ltd <Girdis Super Fund A/C> 6,922,828 2.82%
    Potski Pty Ltd <Potski Super Fund A/C> 6,917,604 2.82%
    Towns Corporation Pty Ltd <PAE Family A/C> 5,850,000 2.38%
    Energy Trading Systems Pty Ltd <MPF A/C> 5,529,411 2.25%
    Kefford Holdings Pty Ltd <The Kefford Family A/C> 4,738,610 1.93%
    Meditsuper Pty Ltd <Medi Consumables P/L S/F A/C> 4,272,281 1.74%
    Development Management & Constructions Pty Ltd 4,247,353 1.73%
    Seguro Super Pty Ltd <Seguro Super Fund A/C> 4,105,695 1.67%
    Bennelong Resources Pty Limited <John Egan Super Fund A/C> 3,500,000 1.42%
    Lotsa Nominees Pty Ltd 3,333,333 1.36%
    Benlee Company Pty Ltd <The Benlee A/C> 3,168,283 1.29%
    Bnp Paribas Noms Pty Ltd <Drp> 3,018,706 1.23%
    Steven Kritzler <S&J Kritzler Super Fund> 2,921,176 1.19%
    Chiang Hao Wong 2,861,557 1.16%
    Uno Seguro Pty Ltd <Uno Seguro Super Fund A/C> 2,800,695 1.14%
    Roo County Pty Ltd 2,757,935 1.12%

    Profile

    since

    Note